...
首页> 外文期刊>Chinese Medical Journal >Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators
【24h】

Expression of platelet-endothelial cell adhesion molecule-1 in human umbilical vein endothelial cells by exposure to advanced glycosylation end products and inflammatory mediators

机译:暴露于晚期糖基化终产物和炎症介质在人脐静脉内皮细胞中血小板内皮细胞粘附分子-1的表达

获取原文
获取原文并翻译 | 示例

摘要

Objective To determine whether advanced glycosylation end products modified bovine serum albumin (AGEs-BSA) affects endothelial cell lateral junction protein, platelet-endothelial cell adhesion molecule-1 (PECAM-1) in the presence or absence of inflammatory mediators. Methods Cultured human umbilical vein endothelial cells (HUVECs) were exposed to AGEs-BSA for 6, 12, 24, and 36 hours, and exposed to AGEs-BSA glycosylated with different concentrations of glucose, tumor necrosis factord-α (TNF-α), interferon (IFN-γ), TNF-α + IFN-γ and AGEs-BSA + TNF-α for 24 hours, respectively. Expression of PECAM-1 mRNA was measured by semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) with β-actin as an internal standard, and sequencing of RT-PCR products was performed to confirm the specificity of amplification for PECAM-1 gene. The endothelial cell surface expression of PECAM-1 was determined by flow cytometry (FCM). Results There were no significant changes in the expression of PECAM-1 mRNA and protein when the cells were exposed to AGEs-BSA with different concentrations or periods ( P>0. 05). However, PECAM-1 expression was reduced in the cells treated with TNF-α, IFN-γ, TNF-α + IFN-γ and AGEs-BSA + TNF-α. The level of PECAM-1 treated with AGEs-BSA + TNF-α was lower than that of TNF-α treated alone (P<0. 01). Conclusions AGEs-BSA had no effect on the expression of PECAM-1 mRNA and protein in cultured HUVEC. With the presence of inflammatory mediator TNF-α, AGEs-BSA decreased the level of PECAM-1, which might reduce the adhesion interaction between adjacent endothelial cells, enhance the permeability of endothelial cells, and might be implicated in the endothelial dysfunction and pathogenesis of atherosclerosis in patients with diabetes mellitus. The significance of this phenomenon in intracellular signal transduction remains to be determined.
机译:目的探讨存在或不存在炎性介质的情况下,晚期糖基化终产物修饰的牛血清白蛋白(AGEs-BSA)是否影响内皮细胞侧向连接蛋白,血小板-内皮细胞粘附分子-1(PECAM-1)。方法将培养的人脐静脉内皮细胞(HUVEC)分别暴露于AGEs-BSA 6、12、24和36小时,然后暴露于糖基化的AGEs-BSA,其中糖基化浓度不同,葡萄糖,肿瘤坏死因子-α(TNF-α) ,干扰素(IFN-γ),TNF-α+IFN-γ和AGEs-BSA +TNF-α分别持续24小时。通过以β-肌动蛋白为内标的半定量逆转录聚合酶链反应(RT-PCR)测量PECAM-1 mRNA的表达,并对RT-PCR产物进行测序以确认PECAM-1扩增的特异性。 1个基因。通过流式细胞术(FCM)确定PECAM-1的内皮细胞表面表达。结果当细胞暴露于不同浓度或不同时期的AGEs-BSA时,PECAM-1 mRNA和蛋白的表达无明显变化(P> 0。05)。然而,在用TNF-α,IFN-γ,TNF-α+IFN-γ和AGEs-BSA +TNF-α处理的细胞中,PECAM-1表达降低。 AGEs-BSA +TNF-α处理的PECAM-1水平低于单独治疗的TNF-α(P <0.01)。结论AGEs-BSA对HUVEC培养的PECAM-1 mRNA和蛋白表达无影响。随着炎症介质TNF-α的存在,AGEs-BSA降低了PECAM-1的水平,这可能减少了相邻内皮细胞之间的粘附相互作用,增强了内皮细胞的通透性,并可能与内皮功能障碍和发病机制有关。糖尿病患者的动脉粥样硬化。这种现象在细胞内信号转导中的重要性尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号